Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ALPS Medical Breakthroughs ETF SBIO

Full chart Compare
Set alert

Price alert · SBIO

All alert types
55.78 USD +2.95 (+5.58%)

At closeNov 6, 2026, 4:00 PM EST

55.78 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

53.34 Day range 55.78
44.13 52-week range 70.79
YTD
+8.90%
1 year
+26.00%

ALPS Medical Breakthroughs ETF

Issuer
ALPS Funds
Asset class
Equity
Expense ratio
0.50%
Assets under management
$186.92M
NAV
55.80
Holdings
103
Inception
2014-12-30
Top 10 weight
32.57%

Top holdings

  1. ORKA Oruka Therapeutics Inc. 4.46%
  2. CGON CG oncology Inc. 4.40%
  3. MANE VeraDermics Inc. 3.80%
  4. EWTX Edgewise Therapeutics Inc. 3.20%
  5. DNTH Dianthus Therapeutics Inc. 3.15%
  6. TVTX Travere Therapeutics Inc. 3.05%
  7. DFTX Definium Therapeutics Inc. 2.92%
  8. RLAY Relay Therapeutics Inc. 2.67%
  9. XENE Xenon Pharmaceuticals Inc. 2.48%
  10. AMLX Amylyx Pharmaceuticals Inc. 2.43%
  11. ACAD ACADIA Pharmaceuticals Inc. 2.39%
  12. DYN Dyne Therapeutics Inc. 2.21%
  13. VRDN Viridian Therapeutics Inc. 2.11%
  14. DNLI Denali Therapeutics Inc. 2.10%
  15. IRON Disc Medicine Inc. 1.98%
  16. IDYA Ideaya Biosciences Inc. 1.97%
  17. TARS Tarsus Pharmaceuticals Inc. 1.97%
  18. ZLAB Zai Lab Ltd. 1.88%
  19. VCEL Vericel Corp. 1.83%
  20. XNCR Xencor Inc. 1.74%
  21. PVLA Palvella Therapeutics Inc. 1.66%
  22. MBX MBX Biosciences Inc. 1.62%
  23. CLDX Celldex Therapeutics Inc. 1.54%
  24. NAMS Newamsterdam Pharma Co. NV 1.48%
  25. LKFT Lakefront Biotherapeutics NV 1.46%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 91.87%
  • Canada 2.37%
  • United Kingdom 1.83%
  • China 1.73%
  • Netherlands 1.62%
  • Switzerland 0.33%
  • Belgium 0.25%

Updated 2026-11-07